赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNY 赛诺菲安万特

交易中 02-03 14:47:38 EST

47.32

+0.05

+0.11%

最高48.23	最低47.20	成交量299.93万
今开47.52	昨收47.27	日振幅2.18%
总市值1,143亿	流通市值1,040亿	总股本24.15亿
成交额1.43亿	换手率0.14%	流通股本21.97亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"赛诺菲安万特","latestPrice":47.3201,"timestamp":1770148055859,"preClose":47.27,"halted":0,"volume":2999305,"delay":0,"changeRate":0.0010598688385867012,"floatShares":2196882861,"shares":2415000000,"eps":3.758364,"marketStatus":"交易中","change":0.0501,"latestTime":"02-03 14:47:38 EST","open":47.515,"high":48.23,"low":47.199,"amount":143063069.3757,"amplitude":0.021811,"askPrice":47.34,"askSize":674,"bidPrice":47.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":3.758364,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770152400000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":47.27,"dividendRate":0.048013,"preHourTrading":{"tag":"盘前","latestPrice":47.48,"preClose":47.27,"latestTime":"09:27 EST","volume":16848,"amount":799900.24608,"timestamp":1770128860030,"change":0.21,"changeRate":0.004443,"amplitude":0.007404},"postHourTrading":{"tag":"盘后","latestPrice":47.48,"preClose":47.27,"latestTime":"19:58 EST","volume":24363,"amount":1151805.806,"timestamp":1770080319370,"change":0.21,"changeRate":0.004443,"amplitude":0.004443},"volumeRatio":0.834451,"impliedVol":0.2614,"impliedVolPercentile":0.1992},"requestUrl":"/m/hq/s/SNY","defaultTab":"news","newsList":[{"id":"2607704988","title":"明星药物Dupixent销售额再创新高！赛诺菲(SNY.US)Q4盈利超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704988","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704988?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:40","pubTimestamp":1769676045,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在重磅皮肤与哮喘药物Dupixent强劲销售表现的推动下，赛诺菲2025年第四季度盈利超出预期，并预测其营收和盈利在2026年将继续增长。在第四季度，Dupixent销售额同比增长32.2%至创纪录的42.46亿欧元，好于分析师预期，巩固了该药物作为赛诺菲业绩增长主要引擎的地位。目前的赛诺菲极度依赖其超级单品Dupixent。赛诺菲周四表示，将计提22.4亿欧元的减值费用，其中大部分与该药物有关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"明星药物Dupixent销售额再创新高！赛诺菲(SNY.US)Q4盈利超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNY","BK4588","BK4007","IE00BFXG1179.USD","BK4585"],"gpt_icon":0},{"id":"1192835607","title":"财报前瞻｜赛诺菲安万特本季度营收预计增17.09%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1192835607","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192835607?lang=zh_cn&edition=full","pubTime":"2026-01-22 10:09","pubTimestamp":1769047767,"startTime":"0","endTime":"0","summary":"赛诺菲安万特将在2026年01月29日发布最新季度财报，市场聚焦收入增长与盈利修复节奏及关键产品组合表现。- 依据一致预期，本季度赛诺菲安万特营收预计为130.64亿美元，同比增17.09%；EBIT预计25.79亿美元，同比增20.78%；调整后每股收益预计1.02美元，同比增37.47%。关于毛利率、净利润或净利率的本季度前瞻，外部一致预期未披露具体数值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜赛诺菲安万特本季度营收预计增17.09%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"gpt_icon":0},{"id":"1104011542","title":"独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1104011542","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104011542?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:01","pubTimestamp":1768474878,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已决定推迟对赛诺菲安万特旗下糖尿病治疗药物Tzield以及Disc Medicine公司血液疾病治疗药物的审评时间表。业内观察人士指出，FDA的审评延期通常涉及对补充数据或生产信息的进一步核查，这属于新药审评流程中的常规环节。对于赛诺菲安万特而言，Tzield作为其糖尿病管线的重要候选药物，审评进度的变化将直接影响该产品的上市时间表。而Disc Medicine的血液疾病药物同样面临关键审评节点，此次延期将对公司的研发里程碑产生连锁影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU0323591593.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU0225283273.USD","LU0689472784.USD","LU1699723380.USD","LU0432979614.USD","LU2471134952.CNY","LU0265550359.USD","LU1291159041.SGD","LU0471298694.HKD","IE00BJJMRY28.SGD","LU1232071149.USD","LU1267930730.SGD","LU1974910355.USD","LU2264538146.SGD","LU0256863811.USD","LU0109394709.USD","LU0708995401.HKD","LU1069347547.HKD","LU2211815571.USD","LU2237443549.SGD","LU2360106947.USD","LU2361044949.HKD","LU1366192091.USD","LU0079474960.USD","LU1280957306.USD","LU2491050154.USD","LU1116320737.USD","LU1585245621.USD","LU2168564222.USD","LU1201861249.SGD","SG9999015945.SGD","SGXZ99366536.SGD","LU0289739699.SGD","LU0980610538.SGD","LU0198837287.USD","LU0238689110.USD","LU1064131342.USD","LU0648001328.SGD","SG9999014898.SGD","IE0004445239.USD","IE00BSNM7G36.USD","LU0070302665.USD","LU2125154778.USD","SG9999014542.SGD","LU0098860793.USD","IE00BBT3K403.USD","BK4550","LU2417539215.USD","LU0354030511.USD","LU2023250504.SGD","LU0353189680.USD","LU1066051225.USD","IE00B4JS1V06.HKD","IE00BFSS7M15.SGD","LU0823416689.USD","LU1551013342.USD","IE00B1BXHZ80.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999018865.SGD","LU0820561909.HKD","LU0208291251.USD","LU1868836757.USD","LU0965508806.USD","IE00B7KXQ091.USD","LU2750360641.GBP","IE00B1XK9C88.USD","LU0106261372.USD","LU0889565916.HKD","LU1116320901.HKD","IE00BJJMRX11.SGD","IE00BN8TJ469.HKD","LU1548497426.USD","LU2491049909.HKD","LU2237443978.SGD","LU2746668974.SGD","SG9999002224.SGD","LU1720051017.SGD","LU2023250843.SGD","LU2087625088.SGD","LU0354030438.USD","LU2750360997.AUD","SGXZ81514606.USD","LU1868837136.USD","LU2357305700.SGD","IE00B4R5TH58.HKD","SG9999014575.USD","LU0820561818.USD","LU1093756168.USD","LU1023059063.AUD","LU1989772840.SGD","IE0004445015.USD","IE00BLSP4239.USD","LU1127390331.HKD","LU2106854487.HKD","BK4534","SG9999015358.SGD","LU1066053197.SGD","LU1093756325.SGD","LU0640476718.USD","IE0009355771.USD","LU0211331839.USD","LU0061475181.USD","BK4139","IE00BKPKM429.USD","LU0058720904.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0943347566.SGD","BK4533","LU2324357040.USD","LU0316494557.USD","LU1623119135.USD","SG9999001176.USD","SGXZ57979304.SGD","LU1934455863.HKD","LU0985320562.USD","SG9999002232.USD","LU2265009873.SGD","LU0266013472.USD","LU0320765646.SGD","IE00BKDWB100.SGD","LU0965509101.SGD","LU0417517546.SGD","LU1712237335.SGD","LU1868837300.USD","LU2471134879.HKD","BK4599","LU0861579265.USD","LU2491050071.SGD","LU0823434583.USD","SG9999018857.SGD","IE000M9KFDE8.USD","LU0786609619.USD","LU1934455277.USD","LU0096364046.USD","SG9999014906.USD","SGXZ51526630.SGD","SGXZ31699556.SGD","BK4007","LU1917777945.USD","LU2461242641.AUD","LU2063271972.USD","LU2236285917.USD","LU0053671581.USD","LU2746668461.USD","LU1868836591.USD","LU2237443895.HKD","LU0203347892.USD","LU2089984988.USD","LU2552382058.USD","LU0823434740.USD","SG9999001440.SGD","LU1035773651.USD","SG9999013999.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","SG9999015978.USD","BK4581","LU1720051108.HKD","SG9999015341.SGD","LU0097036916.USD","LU0265550946.USD","BK4559","IE00B2B36J28.USD","LU1571399168.USD","LU1066051498.USD","LU2361045086.USD","LU2552382215.SGD","LU0477156953.USD","LU1929549753.HKD","LU0456855351.SGD","LU1988902786.USD","LU0672654240.SGD","LU0109391861.USD","LU2125154935.USD","LU2471134796.USD","IE0002141913.USD","SNY","LU0203202063.USD","LU2456880835.USD","IE00B775H168.HKD","LU0320765059.SGD","LU1037948541.HKD","LU2108987350.USD","LU2237443465.HKD","LU2168564495.EUR","LU2237443622.USD","BK4588","LU0385154629.USD","LU1989771016.USD","LU1814569148.SGD","LU2237443382.USD","LU0683600562.USD","LU1983299246.USD","SG9999014880.SGD","IE00BFSS8Q28.SGD","LU2462157665.USD","SG9999015952.SGD","LU0203201768.USD","SG9999014567.USD","SG9999001176.SGD","LU2361044865.SGD","LU1941712348.USD","LU0320765992.SGD","LU2602419157.SGD","LU0787776722.HKD","LU1941712264.USD","LU1430594728.SGD","LU2168564065.EUR","LU2360032135.SGD","SG9999014914.USD","BK4516","IE00BN29S564.USD","LU0965509010.AUD","LU1868836914.USD","LU2168563687.JPY","LU2552382132.HKD","SG9999017495.SGD","LU0203345920.USD","LU1057294990.SGD","IRON","LU0094547139.USD","GB00BDT5M118.USD","LU0320765489.SGD","LU0471298777.SGD","IE0005OL40V9.USD","LU2168564149.EUR","LU1323610961.USD","LU0882574139.USD","LU1061106388.HKD","LU0965509283.SGD","LU0130517989.USD","LU0466842654.USD","LU2471134523.USD","LU1069344957.HKD","IE00BK4W5L77.USD","LU1066051811.HKD","LU2237438978.USD","LU1162221912.USD","BK4585","LU1989772923.USD","LU1934455194.USD","LU1037948897.HKD","LU1551013425.SGD","SG9999014559.SGD","LU1804176565.USD","IE00BWXC8680.SGD","LU2468319806.SGD","LU0234572021.USD","LU0353189763.USD","LU0114720955.EUR","LU0130102774.USD","LU0882574055.USD","SG9999015986.USD","IE00BJT1NW94.SGD","LU1035775433.USD"],"gpt_icon":0},{"id":"2603569197","title":"Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2603569197","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603569197?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:30","pubTimestamp":1768383001,"startTime":"0","endTime":"0","summary":"金吾财讯 | 人工智能初创公司Anthropic与赛诺菲和诺和诺德等生物制药公司合作，推出符合HIPAA法案（Health Insurance Portability and Accountability Act）标准的“Claude for Healthcare”，该工具可整合病历和可穿戴设备数据，并提供预先授权和临床试验工具。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"296243","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","IE00BFXG1179.USD","LU0154236417.USD","BK4588","NVO","IE00BZ1G4Q59.USD","BK4585","BK4599","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","SNY","BK4532"],"gpt_icon":0},{"id":"2601289189","title":"赛诺菲安万特(SNY)盘前升0.5% 普乐司兰钠注射液在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2601289189","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601289189?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:16","pubTimestamp":1767698210,"startTime":"0","endTime":"0","summary":"金吾财讯 | 赛诺菲安万特(SNY)盘前股价上扬，暂升0.51%，报47.75美元。公司宣布，普乐司兰钠注射液（商品名：瑞达普）正式在中国国内获批，用于在饮食控制基础上降低家族性乳糜微粒血症综合征（FCS）成人患者的甘油三酯水平。该药是全球首个作用于创新靶点APOC3（载脂蛋白C-III） mRNA的小干扰RNA药物。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"295988","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","IE00BFXG1179.USD","BK4588","SNY"],"gpt_icon":0},{"id":"2593477294","title":"12月24日美股盘前要闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477294","media":"钛媒体快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477294?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:43","pubTimestamp":1766583786,"startTime":"0","endTime":"0","summary":"钛媒体App 12月24日消息，美股盘前要闻：1. 美国股指期货小幅波动，截至目前，道琼斯指数期货跌0.10%，标普500指数期货跌0.04%，纳斯达克100指数期货跌0.05%。美光此前透露，2026年全年HBM已全部售罄。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224215236a6caa8d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224215236a6caa8d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051811.HKD","LU0124676726.USD","IE0005OL40V9.USD","SG9999014906.USD","SG9999015341.SGD","LU0354030511.USD","LU0965509010.AUD","SG9999014898.SGD","LU2063271972.USD","LU1868836914.USD","LU0942090050.USD","LU2552382132.HKD","LU0545039389.USD","LU2462157665.USD","LU1145028129.USD","IE0009G5SDU7.USD","LU0256863811.USD","LU0203202063.USD","LU1127390331.HKD","LU0820561909.HKD","LU1366333091.USD","LU2552382215.SGD","LU0820561818.USD","LU1720051017.SGD","LU1989771016.USD","LU0784385840.USD","LU1629891620.HKD","LU1366192091.USD","SGXZ31699556.SGD","LU0472753341.HKD","LU2458330169.SGD","LU2756315664.SGD","LU0251132253.USD","LU0072462426.USD","SG9999014914.USD","BK4575","IE00BFSS8Q28.SGD","LU2361044949.HKD","LU2125154935.USD","LU1116320737.USD","LU0080751232.USD","LU2896262040.SGD","LU0823434740.USD","LU1718418525.SGD","HK0000306685.HKD","LU2505996509.AUD","LU1506573853.SGD","IE0001KFT4U8.USD","LU0724617625.USD","LU2023250330.USD","LU1267930730.SGD","LU2347655156.SGD","LU0210536198.USD","LU1244550494.USD","IE000YTNTUN2.SGD","LU0158827781.USD","LU0882574139.USD","LU2237443978.SGD","BK4532","LU0316494557.USD","LU2168564065.EUR","LU2065171311.SGD","IE00BK4W5M84.HKD","LU0354030438.USD","ESmain","LU2054465674.USD","LU2452424414.USD","LU1720051108.HKD","LU0256863902.USD","LU2456880835.USD","BK4579","IE00BBT3K403.USD","LU0079474960.USD","LU0215105999.USD","IE00B5949003.HKD","LU0234570918.USD","BK4588","LU0868494708.USD","IE00B7KXQ091.USD","HK0000320264.USD","LU2242650005.HKD","SSO","IE00B19Z8X17.USD","LU2077746001.SGD","MESmain","LU1551013425.SGD","LU0109392836.USD","LU2265009873.SGD","LU2505996681.GBP","LU1674673428.USD","LU1732800096.USD","LU0096362180.USD","BK4566","LU0786609619.USD","LU1232071149.USD","LU2746668974.SGD","LU2357305700.SGD","LU0345769631.USD","LU2347655073.USD","LU0788109477.HKD","LU2092937148.SGD","LU0353189763.USD","SG9999002224.SGD","LU0466842654.USD","LU1642822529.SGD","BK4505","LU2237443382.USD","LU2168564149.EUR","LU2087625088.SGD","LU0345770993.USD","LU0109391861.USD","LU1917777945.USD","LU0784384876.USD","LU0061475181.USD","LU1316542783.SGD","LU2242649171.HKD","LU0057025933.USD","LU2247934214.USD","LU1868836757.USD","LU2543165471.USD","OEF","LU1989764664.SGD","HK0000320223.HKD","LU0689472784.USD","LU1699723380.USD","IE00BLSP4239.USD","SG9999015986.USD","LU0238689110.USD","LU2360106780.USD","LU0823421333.USD","LU2430703251.USD","IE00B4YYXB79.USD","IE00BLSP4452.SGD","MACW.SI","LU0672654240.SGD","LU0170899867.USD","LU1496350502.SGD","SG9999001424.SGD","IE00B19Z9505.USD","LU1242518857.USD","LU0528227936.USD","LU1815336760.USD","LU0056508442.USD","IE0004445015.USD","LU0823434583.USD","LU2361044865.SGD","LU1935043536.SGD","LU2089284900.SGD","LU0683600562.USD","BK4559","LU0964807845.USD","BK4507","LU2168563687.JPY","SDS","IE0034235303.USD","LU0943347566.SGD","IE00BSNM7G36.USD","LU0077335932.USD","LU0210533765.USD","LU2023250843.SGD","SG9999014567.USD","LU2237443465.HKD","SG9999014575.USD","LU1206713676.USD","LU1815333072.USD","LU2860962120.EUR","LU0957791311.USD","LU0784385170.HKD","LU2065169927.USD","LU0642271901.SGD","LU1839511570.USD","BK4585","LU0823421416.USD","LU2430703178.SGD","GB00BDT5M118.USD","LU0957808578.USD","LU0198837287.USD","BK4512","IE00BJJMRY28.SGD","LU0314106906.USD","LU2028103732.USD","BK4598","IE00BN8TJ469.HKD","LU0158827948.USD","SH","SG9999015358.SGD","IE00BFSS7M15.SGD","LU2191332357.HKD","IE0003U64NQ7.SGD","LU1582986359.USD","LU0784383803.USD","LU1934455194.USD","BK4553","LU1003077747.HKD","UPRO","LU1066051498.USD","IE00B775H168.HKD","LU2271345857.HKD","LU0861579265.USD","LU2756315318.SGD","SG9999014542.SGD","LU0308772762.SGD","SG9999015978.USD","LU2108987350.USD","LU0061474960.USD","IE000ITXATA3.USD","SG9999015945.SGD","LU2237438978.USD","LU0127658192.USD","LU2133065610.SGD","LU0708995401.HKD","LU0289961442.SGD","HK0000306701.USD","SG9999014880.SGD","LU1116320901.HKD","LU1037948897.HKD","LU2097344357.USD","SG9999017495.SGD","IE00BWXC8680.SGD","LU1814569148.SGD","SPXU","LU0795875169.SGD","LU0345768740.USD","SG9999018857.SGD","BK4170","LU2471134952.CNY","IE0004091025.USD","LU0456855351.SGD","LU0494093205.USD","LU1934455863.HKD","LU0096364046.USD","OEX","LU2361045086.USD","LU0082616367.USD","LU0157215616.USD","LU0348723411.USD","BK4533","LU0320765059.SGD","LU2089283258.USD","LU0949170772.SGD","LU1974910355.USD","LU1206712785.SGD","DNLI","LU2471134796.USD","LU2360032135.SGD","LU1084165304.USD","LU1935043023.USD","LU0154236417.USD","LU1046421795.USD","LU2083900584.USD","LU0476273544.USD","LU0949170426.SGD","LU0889565833.HKD","LU2381873111.SGD","LU2750360641.GBP","LU2471134523.USD","LU1582986433.USD","LU0048584097.USD","LU2286300806.USD","LU2106854487.HKD","LU1778281490.HKD","LU2430703095.HKD","IE00BK4W5L77.USD","LU2023251221.USD","LU0912757837.SGD","LU0267386448.USD","LU0553294199.USD","LU2461242641.AUD","LU2023250504.SGD","SPY","BK4504","LU1551013342.USD","LU0965508806.USD","LU0640476718.USD","LU1852331112.SGD","BK4534","LU0210528500.USD","LU0795875086.SGD","LU2111349929.HKD","PATH","SG9999014559.SGD","LU0345770308.USD","LU2097344431.USD","LU2237443549.SGD","IE00B3S45H60.SGD","LU2458330243.SGD","BK4554","LU0985320562.USD","LU1037948541.HKD","LU2487616109.SGD","LU0444971666.USD","LU2417539215.USD","LU1934455277.USD","LU0070217475.USD","LU0314104364.USD","LU2552382058.USD","LU1571399168.USD","LU1301847155.USD","BK4581","LU1242518931.SGD","LU1582987324.SGD","IVV","LU1235294995.USD","LU0345769128.USD","LU2092627202.USD","LU1261432733.SGD","LU0738911758.USD","BK4501","LU2403377893.USD","LU0719512351.SGD","IE00BN29S564.USD","LU0053666078.USD","LU2065170008.USD","LU1244550577.SGD","LU1119994496.HKD","LU1791710400.SGD","BK4515",".SPX","LU1868837136.USD","SG9999015952.SGD","LU0323591593.USD","LU1548497426.USD","LU2237443895.HKD","LU2592432038.USD","LU1732799900.SGD","LU1582987597.SGD","IE000W1ABFV2.USD","BK4576","LU1291159041.SGD","LU0979878070.USD","IE00BJLML261.HKD","LU0444973449.USD","LU1496350171.SGD","IE00B775SV38.USD","LU2750360997.AUD","SG9999018865.SGD","IE00BJTD4N35.SGD","LU2213496289.HKD","LU1989772840.SGD","BK4573","LU2065171402.SGD","SNY","LU1035775433.USD","LU2168564495.EUR","LU0265550946.USD","LU1803068979.SGD","IE00BJTD4V19.USD","IE0004445239.USD","LU0661504455.SGD","LU0345768153.USD","LU2237443622.USD","LU2236285917.USD","LU2250418816.HKD","LU2602419157.SGD","LU1066053197.SGD","IE00BKDWB100.SGD","IE0004086264.USD","LU0097036916.USD","LU1868837300.USD","LU2087621335.USD","LU1244550221.USD","LU0868494617.USD","LU0511384066.AUD","IE00B1BXHZ80.USD","LU0265550359.USD","IE00BJJMRX11.SGD","LU0820562030.AUD","LU0069063385.USD","LU0353189680.USD","LU1069344957.HKD","BK4592","LU0011850046.USD","LU1791710582.SGD","LU0417517546.SGD","LU1989772923.USD","SG9999002232.USD","LU2168564222.USD","LU1066051225.USD","LU0787776722.HKD","LU0149725797.USD","IE00BZ1G4Q59.USD","BK4574","IE0009356076.USD","LU1823568750.SGD","IE00B19Z8W00.USD","SG9999000418.SGD","BK4571","LU1868836591.USD","LU0965509283.SGD","LU1935042215.USD","BK4550","IE000KEQY171.SGD","LU1914381329.SGD","IE00BKVL7J92.USD","LU1935042991.SGD","LU2746668461.USD","LU1804176565.USD","IE00B3SWFQ91.USD","LU2125154778.USD","LU0965509101.SGD","IE00B1XK9C88.USD","BK4527","LU1674673691.USD","LU0689626769.HKD","LU1989764748.USD","IE00B4JS1V06.HKD","LU0289739343.SGD","LU2471134879.HKD","LU0203201768.USD","LU1935042488.USD","LU1280957306.USD","LU0234572021.USD","LU0726765562.USD","LU2420271590.USD"],"gpt_icon":1},{"id":"1175074906","title":"赛诺菲以每股15.50美元的现金价格收购Dynavax所有流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1175074906","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175074906?lang=zh_cn&edition=full","pubTime":"2025-12-24 14:20","pubTimestamp":1766557223,"startTime":"0","endTime":"0","summary":"12月24日，Dynavax夜盘涨近8%！赛诺菲以每股15.50美元的现金价格收购Dynavax公司的所有流通股。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b31cda120fef942502fc01c1d2275ab4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK5011","SNY","DVAX"],"gpt_icon":0},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1057294990.SGD","LU1989771016.USD","LU1571399168.USD","LU1718418525.SGD","BK4534","LU2133065610.SGD","LU2089984988.USD","LU0225284248.USD","SG9999001176.USD","LU1934455194.USD","SG9999014575.USD","LU0265550946.USD","SG9999014559.SGD","LU1201861249.SGD","AMGN","IE00B1BXHZ80.USD","BK4533","LU1941712264.USD","LU2112291526.USD","LU1037948541.HKD","BK4585","SG9999014542.SGD","REGN","BK4581","LU1868836757.USD","LU2360032135.SGD","LU1868837300.USD","LU1061106388.HKD","LU1868836591.USD","LU1430594728.SGD","LU0267386448.USD","LU0320765489.SGD","LU1261432733.SGD","LU2461242641.AUD","LU1023059063.AUD","LU0211331839.USD","LU2125154935.USD","IE0002141913.USD","LU1093756168.USD","SG9999001440.SGD","LU0203345920.USD","LU0321505439.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0985481810.HKD","LU0965508806.USD","LU1699723380.USD","IE0009355771.USD","LU1037948897.HKD","LU0985320562.USD","IE00B2B36J28.USD","LU1032466523.USD","LU1074936037.SGD","LU1868836914.USD","LU1066051225.USD","LU0058720904.USD","LU0882574055.USD","SG9999002224.SGD","LU0225771236.USD","LU0477156953.USD","LU1069347547.HKD","04332","LU2125154778.USD","IE00BFXG1179.USD","LU0965509101.SGD","LU0208291251.USD","LU0965509283.SGD","LU1291159041.SGD","LU0266013472.USD","LU1934455277.USD","IE00BJJMRZ35.SGD","ROG","LU2361044865.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0122379950.USD","LU1989772840.SGD","LU1670710588.SGD","LU2361045086.USD","SG9999001176.SGD","LU0070302665.USD","SG9999014567.USD","SG9999015358.SGD","LU0648001328.SGD","LU0306806265.USD","LU0868494617.USD","SGXZ57979304.SGD","LU1585245621.USD","NVS","LU2324357040.USD","BK4516","LU1066053197.SGD","LU2361044949.HKD","LU2023250843.SGD","SG9999015341.SGD","LU0265550359.USD","LU0980610538.SGD","SG9999013999.USD","LU1670711040.USD","LU0098860793.USD","LU2106854487.HKD","IE00BLSP4452.SGD","AZN","LU0106261372.USD","LU1989772923.USD","GSK","BK4532","LU0234572021.USD","LU1116320737.USD","LU0321505868.SGD","LU0320765646.SGD","LU1162221912.USD","LU2242646821.SGD","IE00BSNM7G36.USD","LU0006306889.USD","LU1974910355.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","IE00BN8TJ469.HKD","LU0203347892.USD","LU0237698245.USD","BK4559","BK4588","LU0456855351.SGD","LU0306807586.USD","LU2242652126.USD","LU1670711123.USD","LU0061475181.USD","SNY","LU2468319806.SGD","JNJ","IE00BLSP4239.USD","LU1868837136.USD","LU1941712348.USD","ABBV","LU0096364046.USD","MRK","LU1983299246.USD","LU1934455863.HKD","LU1035773651.USD","BK4007","GILD","BK4550","LU2023250504.SGD","LU1116320901.HKD","LU1066051498.USD","LU0114720955.EUR","LU0130517989.USD","LU0861579265.USD","LU1929549753.HKD","BMY","LU1323610961.USD","LU0130102774.USD","LU1670710661.SGD","SG9999002232.USD","LU0965509010.AUD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1323610961.USD","IE00B2B36J28.USD","LU0122379950.USD","GILD","BK4585","LU1116320901.HKD","BIIB","LU2089984988.USD","LU0267386448.USD","SG9999014567.USD","LU2361045086.USD","LU1670711123.USD","SG9999002224.SGD","LU0823416689.USD","IE00BQJZX424.USD","IE00BSNM7G36.USD","SNY","LU1023059063.AUD","LU0114720955.EUR","SG9999014559.SGD","BK4534","LU1778281490.HKD","LU2023250504.SGD","LU0980610538.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU1868836757.USD","LU0266013472.USD","LU0289739699.SGD","LU2125154778.USD","LU0321505868.SGD","LU1098665638.USD","LU0234572021.USD","LU1670710661.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1162221912.USD","LU1309081286.SGD","IE00B3T34201.USD","IE0002270589.USD","BK4599","LU0130517989.USD","LU1064927863.SGD","LU1868837300.USD","LU1839511570.USD","LU2324357040.USD","LU0225771236.USD","LU1571399168.USD","LU2361044865.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0106261372.USD","LU0109394709.USD","LU0234570918.USD","LU1228905540.USD","LU0965509101.SGD","LU1868837136.USD","SG9999015978.USD","LU1934455194.USD","LU0320765992.SGD","IE00BWDBJ516.SGD","BK4568","MRK","SG9999014575.USD","SG9999015945.SGD","IE00BLSP4239.USD","LU1116320737.USD","SG9999015341.SGD","LU0161305163.EUR","LU1037948897.HKD","LU1066051498.USD","LU1941712348.USD","LU0321505439.SGD","LU0237698245.USD","IE00BLSP4452.SGD","LU0477156953.USD","LU0985481810.HKD","IE00BKVL7J92.USD","LU2242646821.SGD","LU0265550359.USD","LU0965508806.USD","LU1941712264.USD","LU2133065610.SGD","LU0238689110.USD","BK4516","BK4581","LU0058720904.USD","LU0545562505.USD","LU1035777561.USD","SG9999015952.SGD","LU1202635105.USD","IE00B1BXHZ80.USD","LU0306806265.USD","LU0211331839.USD","LU2112291526.USD","LU0006306889.USD","LU2023250843.SGD","BK4139","NVS","LU0203347892.USD","LU1699723380.USD","LU0648001328.SGD","LU2468319806.SGD","LU0109981661.USD","LU1670710588.SGD","IE00B19Z3581.USD","LU1989771016.USD","IE0009355771.USD","LU1302929846.USD","IE000M9KFDE8.USD","LU1487256676.USD","IE0034235071.USD","LU1670756490.USD","BK4550","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1069347547.HKD","BK4578","BK4559","BK4532","IE00BJJMRZ35.SGD","LU1066051225.USD","LU1061106388.HKD","LU2087621335.USD","LU2361044949.HKD","RHHBY","GSK","LU0061475181.USD","LU2106854487.HKD","LU1917777945.USD","BK5011","LU1291159041.SGD","LU1989772840.SGD","LU1645745479.HKD","IE00BJT1NW94.SGD","LU0971552673.USD","LU1929549753.HKD","LU0320765646.SGD","LU1481600234.SGD","LU1718418525.SGD","LU2360032135.SGD","LU1670711040.USD","LU1046248800.SGD","LU0965509283.SGD","LU1015430645.USD","BK4588","LU2461242641.AUD","BK4566","LU1066053197.SGD","LU0130102774.USD","LU1983299246.USD","SG9999015358.SGD","LU1400636491.USD","IE0002141913.USD","LU0985320562.USD","LU1400636574.HKD","LU1400636657.SGD","LU1674673428.USD","LU0868494617.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","LU1674673691.USD","04332","LU1201861249.SGD","LU0456855351.SGD","LU0965509010.AUD","LU1934455863.HKD","LU0208291251.USD","LU0861579265.USD","BK4583","SG9999014542.SGD","LU0882574055.USD","LU1481599808.USD","LU1868836591.USD","LU1228905037.USD","LU1585245621.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU1261432733.SGD","LU1066051811.HKD","LU1093756168.USD","IE00B7SZLL34.SGD","LU0971552830.HKD","IE00BFXG1179.USD","BK4533","LU1074936037.SGD","LU1868836914.USD","LU1035773651.USD","SG9999001176.USD","LU1037948541.HKD","LU0320765489.SGD","LU1430594728.SGD","BMY","BK4007","LU0070302665.USD","LU0098860793.USD","SG9999002232.USD","LU1032466523.USD","SG9999013999.USD","SG9999001440.SGD","LU2242652126.USD","IE00BBT3K403.USD","LU0265550946.USD","LU0575583348.USD","AMGN","LU0306807586.USD","LU2125154935.USD","SG9999015986.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2592156513","title":"创新药研发充满荆棘，近期多家药企接连宣布“折戟”","url":"https://stock-news.laohu8.com/highlight/detail?id=2592156513","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592156513?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:06","pubTimestamp":1766045160,"startTime":"0","endTime":"0","summary":"创新药被喻为医药行业的“皇冠明珠”，成功上市往往意味着巨额回报与生命希望。如赛诺菲近日公告称，公司研发的治疗晚期多发性硬化症的药物tolebrutinib在一项针对原发性进展型多发性硬化症的后期试验中，未能延迟患者残疾的进展。而在原发性进展型多发性硬化症中，症状会持续恶化，没有任何恢复期。赛诺菲表示将不再就该适应症寻求监管批准，该适应症患者约占患者总数的10%。创新药从早期研发到上市，周期长，成功率低，研发成本高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218160840a45a82aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218160840a45a82aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","LU1989771016.USD","LU1571399168.USD","BK4534","LU2089984988.USD","SG9999001176.USD","LU1934455194.USD","SG9999014575.USD","LU0265550946.USD","SG9999014559.SGD","LU1201861249.SGD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4533","LU1941712264.USD","LU1037948541.HKD","BK4585","SG9999014542.SGD","LU2360032135.SGD","LU1061106388.HKD","LU1430594728.SGD","LU0320765489.SGD","LU2461242641.AUD","LU1023059063.AUD","LU0211331839.USD","LU2125154935.USD","IE0002141913.USD","LU1093756168.USD","SG9999001440.SGD","LU0203345920.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0965508806.USD","LU1699723380.USD","IE0009355771.USD","LU1037948897.HKD","LU0985320562.USD","IE00B2B36J28.USD","LU1066051225.USD","LU0058720904.USD","SG9999002224.SGD","LU0477156953.USD","LU1069347547.HKD","LU2125154778.USD","LU0965509101.SGD","LU0208291251.USD","LU0965509283.SGD","LU1291159041.SGD","LU0266013472.USD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0122379950.USD","LU1989772840.SGD","LU2361045086.USD","SG9999001176.SGD","LU0070302665.USD","SG9999014567.USD","SG9999015358.SGD","LU0648001328.SGD","SGXZ57979304.SGD","LU1585245621.USD","LU2324357040.USD","BK4516","LU1066053197.SGD","LU2361044949.HKD","LU2023250843.SGD","SG9999015341.SGD","LU0265550359.USD","LU0980610538.SGD","SG9999013999.USD","LU0098860793.USD","LU2106854487.HKD","IE00BLSP4452.SGD","LU0106261372.USD","LU1989772923.USD","LU0234572021.USD","LU1116320737.USD","LU0320765646.SGD","LU1162221912.USD","IE00BSNM7G36.USD","LU0006306889.USD","LU1974910355.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","IE00BN8TJ469.HKD","LU0203347892.USD","BK4559","BK4588","SNY","LU2468319806.SGD","IE00BLSP4239.USD","LU1941712348.USD","LU1983299246.USD","LU1934455863.HKD","LU1035773651.USD","BK4007","BK4550","LU2023250504.SGD","LU1116320901.HKD","LU1066051498.USD","LU0130517989.USD","LU0861579265.USD","LU1929549753.HKD","LU0130102774.USD","SG9999002232.USD","LU0965509010.AUD","560600"],"gpt_icon":0},{"id":"2592990089","title":"赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990089","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592990089?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:11","pubTimestamp":1765977087,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月17日，赛诺菲宣布第二代心肌肌球蛋白抑制剂阿夫凯泰获得国家药监局批准上市，用于治疗纽约心脏病协会心功能分级II-III级的梗阻性肥厚型心肌病成人患者，以改善运动能力和症状。阿夫凯泰是一种小分子心肌肌球蛋白抑制剂，由Cytokinetics自主研发。据悉，阿夫凯泰片是肥厚型心肌病领域潜在“同类最佳”的治疗药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFXG1179.USD","SNY","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2591935317","title":"1天两笔交易，超26亿美元！制药巨头抢滩自免赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2591935317","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591935317?lang=zh_cn&edition=full","pubTime":"2025-12-16 12:07","pubTimestamp":1765858063,"startTime":"0","endTime":"0","summary":"临近年关，自身免疫领域迎来两笔重磅交易。12月15日，辉瑞与赛诺菲两大制药巨头相继出手，分别与Adaptive Biotechnologies及Dren Bio达成合作，潜在交易总额超26亿美元，为2025年的BD市场画上浓墨重彩的一笔。该交易包含预付款及高达8.9亿美元的里程碑金额，双方还达成了一项独立的TCR数据授权合作。今年8月，其与基因泰克的个性化TCR细胞疗法合作宣告终止。Dren将获得1亿美元预付款，并有机会获取高达17亿美元的里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216133718a6a810a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216133718a6a810a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU1023059063.AUD","SG9999013999.USD","LU0321505439.SGD","IE0002270589.USD","LU1057294990.SGD","SG9999001176.SGD","BK4550","LU0321505868.SGD","IE00B19Z3B42.SGD","BK4599","LU0306806265.USD","BK4585","BK4588","LU1883839398.USD","LU0122379950.USD","LU0058720904.USD","BK4581","LU1894683264.USD","BK4007","LU1894683348.USD","IE00BBT3K403.USD","SNY","BK4533","LU0225284248.USD","BK4592","PFE","BK4534","SGXZ57979304.SGD","LU1066051498.USD","IE00BLSP4239.USD","LU0170899867.USD","SG9999001176.USD","SG9999003800.SGD","SG9999011175.SGD","LU0289739699.SGD","LU0306807586.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0225771236.USD","LU0868494617.USD","LU0985481810.HKD","LU1066053197.SGD","SG9999002232.USD","SG9999002224.SGD","IE00B19Z3581.USD","LU0234572021.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2591648196","title":"FDA延期叠加试验失败，赛诺菲多发性硬化症药物遭双重暴击","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648196","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648196?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:05","pubTimestamp":1765796736,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"adcb97001031eadac4ba887dc4784d4e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"FDA延期叠加试验失败，赛诺菲多发性硬化症药物遭双重暴击","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SNY"],"gpt_icon":0},{"id":"1153946041","title":"独家报道：美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1153946041","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153946041?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:01","pubTimestamp":1765278094,"startTime":"0","endTime":"0","summary":"独家报道：美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0266013472.USD","LU0070302665.USD","LU2089284900.SGD","LU0047473722.SGD","LU1116320901.HKD","LU1699723380.USD","SG9999015358.SGD","LU1019634622.SGD","LU0889565080.SGD","LU0211331839.USD","SG9999001440.SGD","LU0029864427.USD","LU1066053197.SGD","LU2361044949.HKD","LU0882574055.USD","LU0545039389.USD","LU0114720955.EUR","LU0289739699.SGD","LU0310800379.SGD","LU0526926950.USD","LU0011850046.USD","LU0432979614.USD","LU0122379950.USD","LU0708994859.HKD","IE00B2B36J28.USD","LU1116320737.USD","LU1119994496.HKD","LU1481600234.SGD","LU0575583348.USD","SNY","LU1941712264.USD","LU1323610961.USD","LU0784384876.USD","LU0889566641.SGD","LU0158827948.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU0098860793.USD","LU0960981461.USD","SGXZ57979304.SGD","IE0002141913.USD","LU1162221912.USD","LU0661504455.SGD","SG9999014567.USD","LU1941712348.USD","LU2361045086.USD","LU2125154778.USD","LU0553294199.USD","LU0949170772.SGD","LU1430594728.SGD","IE00BN8TJ469.HKD","LU2108987350.USD","LU1934455277.USD","LU1880407215.USD","IE00B1BXHZ80.USD","IE0009355771.USD","LU2293690249.USD","IE00BBT3K403.USD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU0757432116.USD","BK5011","LU1078025761.USD","LU1814569148.SGD","LU0128525689.USD","LU0265550359.USD","LU0320765489.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0345777659.USD","LU2089283258.USD","LU1496350171.SGD","03165","LU0969580561.USD","LU1037948897.HKD","LU1487256676.USD","LU1929549753.HKD","MRK","LU0972486137.USD","BK4516","LU2114397693.USD","LU0128525929.USD","LU0823399737.USD","LU1066051225.USD","LU1061106388.HKD","LU1989771016.USD","BK4550","LU0784385170.HKD","LU1301847155.USD","LU2468319806.SGD","LU1023059063.AUD","LU2461242641.AUD","LU0234572021.USD","IE00BSNM7G36.USD","LU0211328371.USD","LU0106261372.USD","LU0985320562.USD","LU2023250843.SGD","LU0861579265.USD","LU1069347547.HKD","BK4007","IE00BLSP4239.USD","LU0320765646.SGD","LU2106854487.HKD","SG9999014559.SGD","LU2293690082.USD","SG9999001176.USD","LU0640478417.SGD","LU1267930227.SGD","SG9999014575.USD","LU1153585028.USD","LU2023251221.USD","LU0823416689.USD","LU1291159041.SGD","LU0211327993.USD","LU0976567544.SGD","BK4534","LU2023250504.SGD","LU0557290698.USD","LU0949170426.SGD","LU1084165304.USD","LU1267930490.SGD","LU1880407132.USD","IE00BLSP4452.SGD","LU0963555726.SGD","SG9999002224.SGD","IE00B3T34201.USD","LU0345777147.USD","LU2125154935.USD","LU0238689110.USD","LU1064927863.SGD","SG9999013999.USD","LU2133065610.SGD","LU1035773651.USD","LU0052756011.USD","IE0034235188.USD","BK4559","IE00B4R5TH58.HKD","LU1934455863.HKD","LU0965509283.SGD","LU0006306889.USD","LU1003077747.HKD","LU1153584641.USD","BK4588","LU1496350502.SGD","LU1066051498.USD","LU2279689827.SGD","LU2539964713.USD","LU0792757196.USD","LU1051770623.HKD","LU0211326839.USD","LU0265550946.USD","BK4533","SG9999015341.SGD","LU1019632923.USD","LU0208291251.USD","LU0499090636.EUR","LU1104425308.USD","LU0965509101.SGD","LU0964806797.USD","LU0310799852.SGD","LU2360032135.SGD","LU0171293334.USD","IE00BKPKM643.USD","BK4585","LU0203345920.USD","LU1267930813.SGD","LU1934455194.USD","LU1974910355.USD","LU1003076772.USD","LU2112291526.USD","LU0965509010.AUD","LU1917777945.USD","LU2091194634.USD","LU0496365809.HKD","LU1057294990.SGD","LU1585245621.USD","SG9999014542.SGD","LU0738911758.USD","LU0957799991.USD","LU0997586432.USD","LU1015430645.USD","LU1989772923.USD","AZN","LU1571399168.USD","LU1481599808.USD","LU0784385840.USD","LU0047473722.EUR","LU1037948541.HKD","LU0203347892.USD","LU0784383803.USD","LU0077335932.USD","LU1093756168.USD","LU1066051811.HKD","LU2361044865.SGD","LU1093756325.SGD","LU0211326755.USD","LU0965508806.USD","LU1261432733.SGD","LU1989772840.SGD","SG9999001176.SGD","LU2089984988.USD","LU0310800965.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2577620165","title":"旗舰药物需求增长，赛诺菲安万特三季度利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2577620165","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577620165?lang=zh_cn&edition=full","pubTime":"2025-10-24 14:55","pubTimestamp":1761288921,"startTime":"0","endTime":"0","summary":"重申了全年业绩指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNY"],"gpt_icon":0},{"id":"2576055837","title":"EMA十月药品审评会议：赛诺菲(SNY.US)、Insmed(INSM.US)等公司新药获上市推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055837","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576055837?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:29","pubTimestamp":1760707780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在本周召开的会议上，欧洲药品管理局的专家小组对赛诺菲与Insmed的两款新药做出了推荐在该地区上市的积极意见。除了推荐新药获批外，该委员会还否决了赛诺菲的一款新药，并推荐了8项新的药品适应症扩展申请。赛诺菲表示，这一决定基于该公司关键的LUNA 3期临床试验。该公司表示，CHMP的这一决定令人失望，并将寻求对该决定进行重新审查。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFXG1179.USD","LU0320765992.SGD","BK4139","BK4588","BK4081","LU0889565916.HKD","EMA","SNY","BK4585","LU0053671581.USD","BK4007","INSM","LU0109394709.USD"],"gpt_icon":0},{"id":"2570302992","title":"赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2570302992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570302992?lang=zh_cn&edition=full","pubTime":"2025-09-26 09:05","pubTimestamp":1758848759,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月24日，全球临床试验收录网站显示，赛诺菲的TSLP/IL-13双抗Lunsekimig推进至II/III期阶段，针对慢性阻塞性肺病启动了两项II/III期临床试验。研究的主要终点为基线至第48周中重度COPD恶化的年化发生率。此前，赛诺菲曾公布Lunsekimig治疗哮喘的Ib期概念验证研究数据。数据显示，哮喘患者经400mg Lunsekimig治疗28天后，呼出一氧化碳分数较基线显著降低，较安慰剂组降幅为40.9ppb。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNY","BK4007","BK4585","BK4134","III","TSLP","IE00BFXG1179.USD","BK4588"],"gpt_icon":0},{"id":"2564137720","title":"赛诺菲(SNY.US)全球首创OX40L单抗III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2564137720","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564137720?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:16","pubTimestamp":1756991799,"startTime":"0","endTime":"0","summary":"赛诺菲(SNY.US)宣布Amlitelimab治疗特应性皮炎的III期COAST 1研究达到了所有主要终点和次要终点。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20250904/20250904211559_80523.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250904/20250904211559_80523.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4007","IE00BFXG1179.USD","SNY","BK4585","BK4134","III","BK4588"],"gpt_icon":0},{"id":"2564327214","title":"美股异动 | 赛诺菲(SNY.US)盘前跌近9% 特应性皮炎药物后期试验疗效不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2564327214","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564327214?lang=zh_cn&edition=full","pubTime":"2025-09-04 17:04","pubTimestamp":1756976650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，赛诺菲公司用于治疗皮肤疾病“特应性皮炎”的实验性药物在后期试验中令投资者感到失望，因为该药物的疗效低于预期。消息公布后，截至发稿，该股票美股盘前跌幅高达 9.3%。截至周三收盘，该股票在过去 12 个月里已下跌了 18%。赛诺菲正在寻找接替Dupixent的替代药物。itepekimab是由赛诺菲和再生元共同研发的一种药物，目前该药物正在用于测试治疗曾经吸烟者的慢性阻塞性肺疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","SNY","BK4588","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2564327502","title":"美股异动丨赛诺菲盘前大跌超9%，OX40L数据不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2564327502","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564327502?lang=zh_cn&edition=full","pubTime":"2025-09-04 17:00","pubTimestamp":1756976447,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","IE00BFXG1179.USD","SNY","BK5011","BK4585","BK4134","0O59.UK","III","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sanofi.com","stockEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0375},{"period":"6month","weight":0.0236},{"period":"1year","weight":-0.1301},{"period":"ytd","weight":-0.0246}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司，专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织：DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.01689},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.019125},{"month":3,"riseRate":0.826087,"avgChangeRate":0.032485},{"month":4,"riseRate":0.652174,"avgChangeRate":0.024644},{"month":5,"riseRate":0.521739,"avgChangeRate":-0.004852},{"month":6,"riseRate":0.434783,"avgChangeRate":-0.014772},{"month":7,"riseRate":0.478261,"avgChangeRate":0.015469},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007213},{"month":9,"riseRate":0.541667,"avgChangeRate":0.007782},{"month":10,"riseRate":0.541667,"avgChangeRate":-0.000294},{"month":11,"riseRate":0.583333,"avgChangeRate":-0.002306},{"month":12,"riseRate":0.666667,"avgChangeRate":0.029189}],"exchange":"NASDAQ","name":"赛诺菲安万特","nameEN":"Sanofi SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛诺菲安万特,SNY,赛诺菲安万特股票,赛诺菲安万特股票老虎,赛诺菲安万特股票老虎国际,赛诺菲安万特行情,赛诺菲安万特股票行情,赛诺菲安万特股价,赛诺菲安万特股市,赛诺菲安万特股票价格,赛诺菲安万特股票交易,赛诺菲安万特股票购买,赛诺菲安万特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}